EFMC-ACSMEDI MedChem Frontiers 2019 Congress

Sheila Abril, member of GT1, attended the EFMC-ACSMEDI MedChem Frontiers 2019 congress held in Krakow (Poland), on June 10-13. The American Chemical Society and the European Federation of Medical Chemistry organize this bi-annual event that brings together 300 participants from the Drug R&D academic and industrial sectors (medical chemists, bioinformatics, biologists, pharmacologists, toxicologists, etc.). Sheila had the opportunity to present her work related to multitarget ligands, presenting a poster entitled “Multitarget directed ligands to treat Alzheimer’s Disease: NRF2 inducers, cholinergic neurotransmission modulators and free radical scavengers”.

Congratulations for your work!


Share on facebook
Share on linkedin
Share on twitter
Share on email

Más noticias


Interview with Antonio Cuadrado

“New therapeutic strategies in neurodegenerative diseases”, interview with one of the main researchers of our project, Antonio Cuadrado. An initiative from the UAM Foundation to